The latest research from Fore Pharma, ‘US Antineoplastics Market Highlights – 2015’, provides the US Antineoplastics market valuation, competitive landscape, and Antineoplastics products sales in the US. The research includes US Antineoplastics market size estimates for 2014, Antineoplastics products market share, and Antineoplastics products sales estimates. This research helps executives track competitor product sales and market share in the US Antineoplastics market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US Antineoplastics market.
Scope of the Research:
Antineoplastics as defined in EphMRA Anatomical Therapeutic Chemical classification code L1
Marketed Products: Identify Antineoplastics products marketed including brand name, molecule name, and company
Sales Estimates: Find out estimates for the US Antineoplastics market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate sales valuation of products and the market
Competitive Landscape: You will know the market share of leading Antineoplastics products in 2014 and how they have changed from 2011
Pipeline: Find out key Antineoplastics products in clinical trial phase 3 and phase 2. Coverage includes molecule, mechanism of action, and the company developing the product